🌡️ Current cold-chain storage methods lead to increased costs, reagent waste, and limited access to global markets.
❄️ Freeze-drying is a common method, but it has limitations and requires expertise and infrastructure.
💡 A novel method called capillary-mediated vitrification (CMV) offers a solution without freezing, resulting in stabilized biomolecules that can be stored and shipped at ambient temperatures.
🚀 Upkara’s BioFix™ technology integrates CMV into manufacturing lines, providing customer-centric products with easier storage and distribution.
💪 Join Upkara in changing the future of biomolecule storage and learn more at www.upkara.com/partnership.
Introduction:
The article discusses the challenges associated with the current antibody storage paradigm, which relies on cold-chain infrastructure. It introduces a novel biomolecule stabilization method called capillary-mediated vitrification (CMV), which allows for the storage and shipping of biomolecules at ambient temperatures. The article highlights the advantages of CMV, including simplified assay transfers, extended reagent shelf life, and reduced costs.
- The current antibody storage paradigm, which requires temperature control, leads to increased complexity, waste, and costs.
- Freeze-drying is a common method to reduce cold storage use, but it has limitations and requires extensive expertise.
- The novel CMV method achieves stabilization without freezing, resulting in an amorphous dried product with no activity loss.
- CMV-stabilized biomolecules can be stored and shipped at ambient temperatures, eliminating the need for cold-chain infrastructure.
- BioFix™, a technology developed by Upkara, leverages CMV to provide customer-centric, ambient temperature-stable reagents and assay kits with equivalent performance.
Conclusion:
The use of capillary-mediated vitrification (CMV) as a biomolecule stabilization method offers significant advantages over the current cold-chain storage paradigm. CMV allows for the storage and shipping of biomolecules at ambient temperatures, reducing complexity, waste, and costs. Upkara’s BioFix™ technology provides customer-centric products with extended shelf life and simplified storage. This advancement in antibody storage has the potential to revolutionize the field and improve the efficiency and accessibility of scientific research and development.
